Protein kinase C as a tumor suppressor.
Protein kinase C as a tumor suppressor.
复制标题
DOI:
10.1016/j.semcancer.2017.04.017
复制
发表时间:
2018-03
影响因子:
14.5
通讯作者:
Newton AC
中科院分区:
文献类型:
--
作者:
Newton AC
Protein kinase C (PKC) has historically been considered an oncoprotein. This stems in large part from the discovery in the early 1980s that PKC is directly activated by tumor-promoting phorbol esters. Yet three decades of clinical trials using PKC inhibitors in cancer therapies not only failed, but in some cases worsened patient outcome. Why has targeting PKC in cancer eluded successful therapies? Recent studies looking at the disease for insight provide an explanation: cancer-associated mutations in PKC are generally loss-of-function (LOF), supporting an unexpected function as tumor suppressors. And, contrasting with LOF mutations in cancer, germline mutations that enhance the activity of some PKC isozymes are associated with degenerative diseases such as Alzheimer's disease. This review provides a background on the diverse mechanisms that ensure PKC is only active when, where, and for the appropriate duration needed and summarizes recent findings converging on a paradigm reversal: PKC family members generally function by suppressing, rather than promoting, survival signaling.
登录
查看更多内容
影响因子:
64.5
作者:
Antal CE;Hudson AM;Kang E;Zanca C;Wirth C;Stephenson NL;Trotter EW;Gallegos LL;Miller CJ;Furnari FB;Hunter T;Brognard J;Newton AC
通讯作者:
Newton AC
影响因子:
64.5
作者:
Creixell P;Schoof EM;Simpson CD;Longden J;Miller CJ;Lou HJ;Perryman L;Cox TR;Zivanovic N;Palmeri A;Wesolowska-Andersen A;Helmer-Citterich M;Ferkinghoff-Borg J;Itamochi H;Bodenmiller B;Erler JT;Turk BE;Linding R
通讯作者:
Linding R
影响因子:
--
作者:
Bernatsky, S;Boivin, JF;Clarke, A
通讯作者:
Clarke, A
影响因子:
11.2
作者:
Barcelo, Carles;Paco, Noelia;Agell, Neus
通讯作者:
Agell, Neus
影响因子:
5.8
作者:
BLUMBERG, PM;JAKEN, S;YEH, E
通讯作者:
YEH, E